Cytotoxic Mechanisms of Klebsiella Oxytoca in Gastrointestinal Disorders

Klebsiella oxytoca is a gut‐resident bacterium that can turn pathogenic through the production of small‐molecule cytotoxins. Two major virulence factors, tilimycin and tilivalline, belong to the pyrrolobenzodiazepine family and exert distinct but overlapping effects on the intestinal epithelium. Tilimycin is a DNA‐alkylating genotoxin that induces strand breaks, genetic instability and apoptosis in colonic epithelial cells, thereby compromising barrier integrity and driving inflammatory responses. Tilivalline, formed from tilimycin by non‐enzymatic reaction with indole, disrupts microtubule dynamics and also triggers epithelial cell death. Beyond direct cytotoxicity, these metabolites perturb the resident microbiota, promote mutagenesis in co‐colonising pathogens and facilitate antibiotic‐associated haemorrhagic colitis. Regulatory networks such as two‐component systems and global transcription factors (for example OmpR and CRP) tightly control toxin biosynthetic operons in response to environmental cues. The pathogenicity of K. oxytoca thus arises from a combination of genotoxic damage, impairment of tight junctions, microbial ecosystem disruption and finely tuned genetic regulation, with important implications for antibiotic stewardship, diagnostic biomarker development and novel therapeutic targeting.

Research from Nature Portfolio

Recent studies have elucidated the broader ecological impact of tilimycin secretion in the antibiotic‐treated gut. Investigations in murine models demonstrate that transient surges in tilimycin not only erode epithelial integrity via apoptosis and DNA lesions but also suppress overall microbial diversity. Sequencing analyses reveal that tilimycin acts as a pro‐mutagenic agent, accelerating the emergence of antibiotic resistance in co‐resident opportunists such as Escherichia coli and Klebsiella pneumoniae. These findings highlight a feedback loop in which antibiotic use selects for toxigenic K. oxytoca, whose cytotoxins then destabilise the gut ecosystem and foster multidrug‐resistant populations.

Cytotoxic Mechanisms of Klebsiella Oxytoca in Gastrointestinal Disorders publication trend

The graph below shows the total number of articles in cytotoxic mechanisms of klebsiella oxytoca in gastrointestinal disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Tilimycin: A DNA‐alkylating pyrrolobenzodiazepine that causes genotoxic damage and epithelial apoptosis.

Tilivalline: A pyrrolobenzodiazepine derived from tilimycin that disrupts microtubule function and induces cell death.

Pyrrolobenzodiazepine: A class of bacterial metabolites characterised by a fused tricyclic scaffold with DNA‐binding properties.

Nonribosomal peptide synthetase (NRPS): A modular enzyme complex that assembles peptide‐based toxins without mRNA templates.

Two‐component regulatory system: A bacterial signal transduction mechanism comprising a sensor kinase and response regulator that modulates gene expression in response to environmental stimuli.

References

1. Microbiota-derived genotoxin tilimycin generates colonic stem cell mutations. Cell Reports (2023).
2. The Response Regulator OmpR Negatively Controls the Expression of Genes Implicated in Tilimycin and Tilivalline Cytotoxin Production in Klebsiella oxytoca. Microorganisms (2025).
3. Enterotoxin tilimycin from gut-resident Klebsiella promotes mutational evolution and antibiotic resistance in mice. Nature Microbiology (2022).
4. Biosynthesis of the Enterotoxic Pyrrolobenzodiazepine Natural Product Tilivalline. Angewandte Chemie International Edition (2017).
5. A tricyclic pyrrolobenzodiazepine produced by Klebsiella oxytoca is associated with cytotoxicity in antibiotic-associated hemorrhagic colitis. Journal of Biological Chemistry (2017).
6. Tilivalline- and Tilimycin-Independent Effects of Klebsiella oxytoca on Tight Junction-Mediated Intestinal Barrier Impairment. International Journal of Molecular Sciences (2019).
7. cAMP Receptor Protein Positively Regulates the Expression of Genes Involved in the Biosynthesis of Klebsiella oxytoca Tilivalline Cytotoxin. Frontiers in Microbiology (2021).